Section 134(1) requires Board approval of financial statements, including consolidated statements where applicable, before signature on behalf of the Board. The Board-signature route is an authorised chairperson or two directors, one of whom must be the managing director if there is one. The CEO, CFO and company secretary also sign wherever appointed. An OPC has the stated one-director route. See Companies Act, 2013, section 134(1).
Choose the route from evidence, not convenience
An authorised chairperson is a statutory alternative to the two-director Board-signature route. Being chairperson alone is not evidence of the required Board authorisation. Conversely, do not import the two-director route’s managing-director requirement into the authorised-chairperson alternative as an additional universal signature. Identify the actual route in the approval papers and retain its authority.
Under the two-director route, a company with a managing director cannot simply select any two other directors and call the requirement complete. Under either ordinary route, assess the CEO, CFO and company secretary wherever appointed. The text does not make their signature requirement disappear merely because the accounts were prepared by a finance team or an external accountant. It does not say an executive must also be a director before the executive role is relevant.
Separate role requirements from the number of people
A role matrix should show appointment evidence, the person holding each role and the capacity in which the person signs. Where one person lawfully holds more than one capacity, resolve the appropriate execution and capacity evidence with the company-secretarial adviser; do not demand an invented number of different human beings from a mere list of roles. The numerical examples deliberately assume different people for all roles other than the stated managing-director inclusion within the two directors.
Where no CEO, CFO or company secretary has been appointed, verify that the absence itself is lawful under applicable appointment provisions. Section 134’s wherever-appointed wording is not an exemption from mandatory appointments elsewhere. A company cannot repair a missing required appointment merely by omitting a signature line. This guide does not determine KMP appointment thresholds.
Keep approval, audit and circulation consistent
The sequence in section 134(1) is Board approval before the described signing for submission to the auditor for the report. A draft signature sheet circulated before approval is not proof of that statutory sequence. Match the approved version to the final signed statements and the auditor’s report and preserve any changes and further approval needed. Do not describe the auditor’s own signature as a substitute for signatures on behalf of the company.
Consolidated financial statements are expressly included. Track the relevant sets, periods and versions, not just a single standalone cover page. Signature entries across two sets are not necessarily twice as many different signatories. The OPC wording is a separate statutory route; do not extrapolate it to an ordinary closely held company because it has one dominant shareholder. Board-report signing, member circulation and ROC filing have their own requirements and are not all resolved by this financial-statement signature matrix.
Six worked illustrations
All facts and amounts below are fictional. Assumptions describe the model, not additional statutory rules.
Illustrative example 1: Authorised chairperson and three executives
The company uses a properly authorised chairperson. A CEO, CFO and company secretary are appointed, each a different person. The matrix has one Board-route signatory plus three executive-role signatories: four distinct people on these facts. Do not demand a second director solely because the alternative two-director route exists.
Illustrative example 2: Two directors with a managing director
The company has a managing director and uses the two-director route. One director signatory is that managing director; the other is a different director. Three separately appointed executives hold the CEO, CFO and company-secretary roles and are distinct from those directors. The stated matrix has five distinct people: two plus three.
Illustrative example 3: Lawfully absent executive appointments
Assume a company lawfully has no appointed CEO, CFO or company secretary and no managing director, and uses the two-director route. Its stated section 134(1) matrix has two director signatories. This example does not decide whether another company is legally entitled to leave those executive posts unfilled.
Illustrative example 4: Two signatures but wrong director capacity
A company with a managing director obtains signatures from two non-MD directors, plus three distinct appointed executives, without using the authorised-chairperson route. Five people have signed, but the director-capacity test fails. Replacing one of the two director signatories with the managing director keeps the count at five and fixes this particular matrix defect; check execution and approval evidence separately.
Illustrative example 5: OPC route
For an OPC applying the express section 134(1) alternative, one director signs. It is not a two-director requirement reduced by an informal shareholder waiver. Compare one required director under this route with two under the assumed ordinary director route, without extending the OPC rule to a non-OPC.
Illustrative example 6: Two statement sets
Assume the same five properly selected signatories under example 2 execute each of the standalone and consolidated sets. There are ten signatory appearances across the two sets, but five distinct people. Version and set completeness must be checked; ten signatures on the wrong standalone version do not establish that the consolidated statements were executed.
Ten-step verification table
| Step | Action | Evidence |
|---|---|---|
| 1 | Identify company type | OPC or ordinary route and relevant applicability facts. |
| 2 | Confirm the statement sets | Standalone, applicable consolidated statements and exact versions. |
| 3 | Evidence Board approval | Resolution/minutes and approved documents before signing. |
| 4 | Choose the Board-signature route | Authorised chairperson or two directors recorded explicitly. |
| 5 | Verify chairperson authorisation | Actual Board authority if that alternative is used. |
| 6 | Check managing-director capacity | MD included within the two-director route where there is an MD. |
| 7 | Map appointed executives | CEO, CFO and company-secretary appointments and signature capacities. |
| 8 | Check lawful vacancies and overlaps | Separate appointment-compliance review and any lawful dual-capacity evidence. |
| 9 | Reconcile audit submission | Final signed version and auditor-report trail consistent with the sequence. |
| 10 | Archive completion evidence | Executed sets, approval, authority and separate circulation/filing controls. |
Sixteen practitioner FAQs
1. Does the Board approve before signature?
Section 134(1) expressly requires approval before the described signing.
2. Can the chairperson sign instead of two directors?
Yes, where the chairperson is authorised by the Board under the stated alternative.
3. Does chairperson status alone prove authorisation?
No. Retain the Board authority for that route.
4. When must the managing director be among two directors?
Where the two-director route is used and the company has a managing director.
5. Does every ordinary route require two directors?
No. The authorised-chairperson alternative is separate.
6. Do appointed CEO, CFO and CS roles matter?
Yes. Section 134(1) expressly includes them wherever appointed.
7. Must an executive also be a director before signing as executive?
The stated executive-role requirement is not confined in the text to executives who are directors.
8. Can the finance preparer substitute for the CFO?
Not merely by preparing the accounts. Verify the statutory role and authority.
9. Does the auditor’s report signature replace company signatures?
No. These are different capacities and requirements.
10. Does a role list prove a minimum number of different people?
Not necessarily. Resolve lawful overlapping capacities and execution evidence; the examples assume distinct people.
11. Does absence of a CEO or CS always justify omission?
First check whether the absence is lawful under applicable appointment requirements.
12. Are consolidated statements included?
Yes. Section 134(1) expressly includes them where applicable.
13. Can one standalone signature sheet prove every set was signed?
No. Identify the actual statements, sets, periods and versions executed.
14. Is the OPC rule available to any one-shareholder-controlled company?
No. Establish actual OPC status and the applicable statutory route.
15. Does this matrix complete Board-report signing?
No. Review that document’s own signing requirements separately.
16. What should the closing reviewer retain?
Approved versions, selected route, authorisation, appointment/capacity evidence and executed standalone/consolidated sets.
Conclusion
Build a section 134(1) signature matrix: evidence Board approval, choose the authorised-chairperson or two-director route, and include appointed executive signatories.